2-219210282-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005689.4(ABCB6):āc.2368A>Gā(p.Asn790Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005689.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCB6 | ENST00000265316.9 | c.2368A>G | p.Asn790Asp | missense_variant | Exon 18 of 19 | 1 | NM_005689.4 | ENSP00000265316.3 | ||
ENSG00000284820 | ENST00000446716.5 | n.*4152A>G | non_coding_transcript_exon_variant | Exon 21 of 22 | 2 | ENSP00000398528.1 | ||||
ENSG00000284820 | ENST00000446716.5 | n.*4152A>G | 3_prime_UTR_variant | Exon 21 of 22 | 2 | ENSP00000398528.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251472Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135908
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461888Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727244
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2368A>G (p.N790D) alteration is located in exon 18 (coding exon 18) of the ABCB6 gene. This alteration results from a A to G substitution at nucleotide position 2368, causing the asparagine (N) at amino acid position 790 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at